Leading players in the global cell culture media, sera, and reagents market comprise of Sartorius, Sigma-Aldrich Co., LLC, Thermo Fisher Scientific, Dickinson & Company, Becton, General Electric, Corning, Lonza, Merck, Eppendorf, and Promocell. These firms accounts for significant share in the entire market. Owing to advancement in technology, the firms are now able to come up with improved and more effective critical therapeutics and biomolecules, by cell culture processes. Several pharmaceutical firms are indulging in mergers and acquisitions to improve their market position and betterment of their product portfolios. Moreover, rise in investments in particular bio-manufacturing process type is anticipated to attract companies so that they focus on research and development activities in forthcoming years.
According to Transparency Market Research, the global cell culture media, sera, and reagents market is expected to register a steady CAGR of 7.1% during the forecast period from 2014 to 2022. The market value by the end of 2022 is valued to reach around worth US$11.3 bn. In year 2013, the market value was around US$6.0 bn.
Request A Sample-
In terms of application, the global cell culture media, sera, and reagents market is dominated by bio-pharmaceuticals segment. The segment held the highest share in terms of revenue. Owing to increasing demand for non-traditional drugs, the segment is foreseen to experience a substantial growth in demand within the forecast period. On the basis of geography, North America region is anticipated to lead the global cell culture media, sera, and reagents market. The region is prognosticated to be valued around worth US$3.7 bn by 2022. Whereas, in 1024, the region was valued around worth US$2.2 bn. The region is growing due to rise in number of people suffering from tumor and other chronic diseases related to metabolism.